Search results
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 7 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required...
A Guide to Managing COVID This Summer
New York Times· 1 day agoTwo of these variants, KP.3 and KP.2, now account for nearly half of all cases, and data from the Centers for Disease Control and Prevention shows a...
'Healed on the inside': Polk man chronicles how God and family got him through cancer fight
The Ledger via Yahoo News· 11 hours agoDoctors decided that Foley was a candidate for immunotherapy, a protocol intended to help the...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 7 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 7 days agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
Donanemab’s solid day
Politico· 2 days agoMODERNA: COMBO FLU-COVID SHOT SHOWS PROMISE — A dual shot for flu and Covid-19 had a higher immune response than vaccines on the market used in a Phase ...
Donanemab for Alzheimer's Gets Thumbs Up From FDA Panel
Medscape· 4 days agoAn 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
Amid big Bayer shakeup, drugmaker loses Berkeley-based biotech chief - San Francisco Business Times
The Business Journals· 2 days agoJens Vogel, who as global head of biotech led Bayer AG's push into cell therapy manufacturing from...